Zevra Therapeutics is a company headquartered in the United States.
Zevra Therapeutics develops and delivers life-changing therapeutics for rare diseases, focusing on treatments for conditions such as Niemann-Pick disease type C, urea cycle disorders, and vascular Ehlers-Danlos syndrome.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.